hexamethonium has been researched along with Insulin Resistance in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Excerpt | Relevance | Reference |
---|---|---|
"We examined the effect of pioglitazone, a thiazolidinedione derivative that increases insulin sensitivity without increasing insulin secretion, on the development and maintenance of hypertension in sucrose-fed SHR." | 3.69 | Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR. ( Fujita, H; Hatta, T; Itoh, H; Kawa, T; Kiyama, M; Miki, S; Moriguchi, J; Morimoto, S; Nakagawa, M; Nakamura, K; Nakata, T; Sasaki, S; Takeda, K; Uchida, A, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Uchida, A | 1 |
Nakata, T | 1 |
Hatta, T | 1 |
Kiyama, M | 1 |
Kawa, T | 1 |
Morimoto, S | 1 |
Miki, S | 1 |
Moriguchi, J | 1 |
Nakamura, K | 1 |
Fujita, H | 1 |
Itoh, H | 1 |
Sasaki, S | 1 |
Takeda, K | 1 |
Nakagawa, M | 1 |
1 other study available for hexamethonium and Insulin Resistance
Article | Year |
---|---|
Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR.
Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Captopril; Catecholamines; Dietary | 1997 |